Drug combination extends survival of patients with pancreatic cancer

A multicenter phase III clinical trial has demonstrated that nab-paclitaxel (Abraxane) plus gemcitabine extends the survival of late-stage pancreatic cancer patients compared with standard treatment.

New drug combination improved overall survival in advanced pancreatic cancer

Overall survival was significantly improved in patients with late-stage pancreatic cancer who received a new combination of cancer drugs compared with those who received standard treatment.

Cloud data on cancer may lead to more effective treatments

Cloud technology is now being used to collect detailed information from thousands of cancer samples with the goal of helping doctors make better predictions about how a patient's illness will progress and what type of treatment will be most effective.

Deviations from radiation protocols increase the risk of treatment failure and death

When measures are implemented to ensure that radiation protocols are followed, deviations decrease and overall survival improves in patients with cancer.

Diabetes from pancreas removal may be manageable side effect

Patients who undergo total pancreatectomy due to cancer or precancerous cysts in the pancreas may be able to achieve glycemic control.

Quantity/quality of life in pancreatic cancer examined

Knowing how much time people with pancreatic cancer spend in the hospital or in medical care can help clinicians make treatment recommendations.

"Inoperable" pancreatic cancer may be treatable after all

Oncologists at M.D. Anderson Cancer Center found the key to screening for pancreatic cancer lies in the interpretation of preoperative CT scans.

Chemotherapy can help after periampullary cancer resection

Adjuvant chemotherapy administered after surgery for cancers near the pancreas confers a modest but statistically significant survival benefit.

Clinical Trial: Vaccine Therapy With or Without Cyclophosphamide in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Stage I or Stage II Pancreatic Cancer That Can Be Removed by Surgery

Clinical Trial: Early Increase in Blood Flow (EIBS) in the Duodenum in Patients With Pancreatic Cancer

Clinical Trial: Stool Testing for Pancreatic Cancer

Clinical Trial: Computer Tools for Improving Early Diagnosis and Treatment in Healthy Volunteers or Patients With Pancreatic Cancer or Who Are At Risk For Pancreatic Cancer or Who Have a Noncancer Pancreatic Disorder

Clinical Trial: A Pilot Study, Evaluating the Efficacy of Regulatory T-cell Suppression by Ontak in Metastatic Pancreatic Cancer